Knight Therapeutics | Ativo Circulante



Current Assets Alterar Data
Acasti Pharma USD 11.94M 4.12M 2024-12
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Avita Medical AUD 57M 15.96M 2024-12
Canopy Growth CAD 341.08M 50.58M 2024-12
Cronos Group USD 936.11M 23.06M 2024-12
Dianthus Therapeutics USD 287.49M 78.2M 2024-09
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
IQVIA Holdings USD 5.83B 197M 2024-12
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Moderna USD 8.1B 1.57B 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Organon & Co USD 4.76B 247M 2024-09
Revvity USD 2.35B 98.8M 2024-12
Tectonic Therapeutic USD 162.6M 24.79M 2024-09
Tilray USD 707.34M 18.54M 2024-11
Viatris USD 9.52B 1.79B 2024-12
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12



Knight Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.